March 27, 2020 / 6:41 AM / 9 days ago

Sanofi and U.S. group Translate Bio to work on COVID-19 vaccine

FILE PHOTO: The logo of Sanofi is seen during the annual results news conference in Paris, France, February 6, 2020. REUTERS/Benoit Tessier

PARIS (Reuters) - French healthcare company Sanofi Pasteur and U.S. company Translate Bio announced on Friday plans to collaborate on developing a vaccine to treat the coronavirus, which has killed thousands around the world.

The companies said Translate Bio would work on discovering, designing, and manufacturing a number of SARS-CoV-2 vaccine candidates, while Sanofi would provide its expertise in the field of vaccines and support from its research networks.

“We are committed to leveraging different ways to address the COVID-19 public health crisis by testing treatments, as well as two vaccines using different platforms,” said David Loew, Global Head of Vaccines at Sanofi, in a statement

“We believe the more approaches we explore, the better our likelihood of success in achieving this goal.”

Reporting by Sudip Kar-Gupta; Editing by Shri Navaratnam

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below